Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2020-05-12 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
关于公开发行可转换公司债券摊薄即期回报与填补措施及相关主体承诺的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by a company regarding the issuance of convertible bonds and the impact on immediate returns (dilution) along with measures to compensate for this dilution. It includes detailed financial assumptions, risk disclosures, investment project descriptions, and commitments by controlling shareholders and management to uphold these measures. The document references regulatory guidelines from the China Securities Regulatory Commission and discusses capital raising activities and their financial impact. It is not a full financial report like an annual or interim report, nor is it a transcript, audit report, or governance document. It is a detailed update on a capital raising event and related financing measures. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (5892 characters) and content support this classification with high confidence.
2020-05-12 Chinese
内部控制鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as an "内部控制鉴证报告" (Internal Control Assurance Report) and includes detailed evaluation and opinion on the effectiveness of internal controls related to financial reporting as of March 31, 2020. It is issued by an accounting firm (致同会计师事务所) and addressed to the shareholders of the company. The report discusses the scope, standards, and results of the internal control evaluation, including the absence of significant deficiencies. It is not a full annual or quarterly financial report but a standalone assurance report on internal controls related to financial statements. This matches the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to internal controls. The document is substantive and over 12,000 characters, so it is not a mere announcement or certification. Therefore, the correct classification is AR with high confidence. Q1 2020
2020-05-12 Chinese
监事会对公司内部控制自我评价报告的核查意见
Regulatory Filings Classification · 95% confidence The document is a statement from the Supervisory Board regarding the company's internal control self-evaluation report for the period ending March 31, 2020. It references compliance with laws and regulations and provides an opinion on the internal control report. The document is short (510 characters) and serves as an announcement or opinion on the internal control report rather than the report itself. It does not contain detailed financial data or the full report. Therefore, it fits best under Regulatory Filings (RNS), which covers compliance documents and miscellaneous regulatory announcements that do not fit other categories.
2020-05-12 Chinese
关于召开2020年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice for the convening of the 2020 second extraordinary general meeting of shareholders of the company. It includes information about the meeting date, voting procedures (both onsite and online), agenda items for shareholder approval, and instructions for proxy voting. The agenda focuses heavily on the proposal for the public issuance of convertible bonds and related matters. The document is not a report of financial results or an audit, nor is it a transcript or presentation. It is a formal announcement and notice to shareholders about the meeting and the items to be voted on. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2020-05-12 Chinese
关于最近五年未被证券监管部门和交易所处罚或采取监管措施的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company stating that it has not been subject to any regulatory penalties or measures in the past five years. It mentions compliance with securities laws and regulations and is related to the company's intention to issue convertible bonds. The document is only 490 characters long and does not contain any financial statements or detailed reports. It is an official regulatory announcement about the company's status with respect to regulatory actions, not a full report or financial filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-05-12 Chinese
第四届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution from the first meeting of the fourth Supervisory Board of the company. It details the election of the Supervisory Board Chairman and confirms the legality and validity of the meeting and voting process. There is no financial data, no detailed report, no earnings or audit information, and no mention of a report being attached or published. This is a governance-related announcement about board composition and management structure. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on management changes, not a full report or regulatory filing.
2020-05-10 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.